Strengthening tuberculosis (TB) prevention, diagnosis, and treatment in Southeast Asia to end TB
This grant funds innovative efforts in Southeast Asia to reduce TB by improving prevention, early diagnosis, and treatment, including new screening, vaccines, and therapies for drug-resistant TB.
Funder: Centers for Disease Control-GHC
Due Dates (Anticipated): June 2026 (full application deadline, projected)
Funding Amounts: Approx. $3,000,000 total for Year 1 (subject to availability); 3 expected awards; actual ceiling/floor TBD
Summary: Supports efforts to reduce tuberculosis morbidity and mortality in India, the Philippines, and Vietnam through strengthened prevention, diagnosis, treatment, and surveillance.
Key Information: This is a forecasted opportunity; all dates and funding are projections and subject to change.
Description
This forecasted opportunity from the CDC Global Health Center aims to reduce tuberculosis (TB) morbidity and mortality in India, the Philippines, and Vietnam. The program focuses on strengthening TB case finding (screening, testing, diagnostic evaluation), prevention (including TB preventive treatment), treatment (with improved regimens and linkage to care), and surveillance. Activities will emphasize innovative and evidence-based approaches to improve diagnosis—including for drug-resistant TB—expand preventive and treatment services, and enhance data-driven decision-making for public health action. The initiative targets countries with a high TB burden, aligning with U.S. global health priorities.
